Bombay Super Hybrid Seeds Ltd vs Gkb Ophthalmics Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 10, 2026

Key Highlights

The Latest Trading Price of Bombay Super Hybrid Seeds Ltd is ₹ 84 as of 09 Oct 15:30 . The P/E Ratio of Bombay Super Hybrid Seeds Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of GKB Ophthalmics Ltd changed from 36.4 on March 2022 to 23.6 on March 2026 . This represents a CAGR of -8.30% over 5 years The Market Cap of Bombay Super Hybrid Seeds Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Market Cap of GKB Ophthalmics Ltd changed from ₹ 41.33 crore on March 2021 to ₹ 26.46 crore on March 2026 . This represents a CAGR of -7.16% over 6 years The revenue of Bombay Super Hybrid Seeds Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of GKB Ophthalmics Ltd for the Jun '26 is ₹ 33.77 crore as compare to the Mar '26 revenue of ₹ 30.6 crore. This represent the growth of 10.36% The ebitda of Bombay Super Hybrid Seeds Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of GKB Ophthalmics Ltd for the Jun '26 is ₹ 3.36 crore as compare to the Mar '26 ebitda of ₹ 2.39 crore. This represent the growth of 40.59% The net profit of Bombay Super Hybrid Seeds Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The net profit of GKB Ophthalmics Ltd changed from ₹ -0.04 crore to ₹ 1.85 crore over 9 quarters. This represents a CAGR of NaN% The Dividend Payout of Bombay Super Hybrid Seeds Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of GKB Ophthalmics Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Bombay Super Hybrid Seeds Ltd

Bombay Super Hybrid Seeds Limited was originally incorporated as 'Jadavjibhai Devrajbhai Patel' a partnership firm formed on April 01, 2000.
The name of Partnership Firm was changed to 'Patel Jadavjibhai Devrahbhai' vide Partnership Deed dated October 01, 2012.
The name further changed to 'Bombay Super Agriseeds' dated April 01, 2014 and again was changed to 'Bombay Super Hybrid Seeds' dated June 28, 2014.
Further, the Partnership Firm converted into Company and the name changed to 'Bombay Super Hybrid Seeds Private Limited' on July 28, 2014.
Thereafter, Company subsequently converted into a Public Limited Company and retained the change in name to 'Bombay Super Hybrid Seeds Limited' on September 14, 2017. The company is engaged in the business of Production, Processing, and Marketing of Hybrid and GM Seeds.

About GKB Ophthalmics Ltd

Incorporated in December, 1981, GKB Opthalmics Limited was granted a licence as a 100% EOU in 1982.
The Company set up a plant at Tivim, Goa, with financial assistance from the Economic Development Corporation of Goa, Daman and Diu Limited and The Maharashtra State Financial Corporation.
Presently, the Company is engaged in manufacture and sale of unfinished ophthalmic lenses and manufactures 14,000 pieces per day of plastic lenses. The company is engaged in the manufacture and export of high-quality, single-vision mineral opthalmic lenses.
Commercial production commenced in May '83.
It has an installed capacity of 30 lac lenses pa.

FAQs for the comparison of Bombay Super Hybrid Seeds Ltd and GKB Ophthalmics Ltd

Which company has a larger market capitalization, Bombay Super Hybrid Seeds Ltd or GKB Ophthalmics Ltd?

Market cap of Bombay Super Hybrid Seeds Ltd is 881 Cr while Market cap of GKB Ophthalmics Ltd is 30 Cr

What are the key factors driving the stock performance of Bombay Super Hybrid Seeds Ltd and GKB Ophthalmics Ltd?

The stock performance of Bombay Super Hybrid Seeds Ltd and GKB Ophthalmics Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Bombay Super Hybrid Seeds Ltd and GKB Ophthalmics Ltd?

As of October 10, 2026, the Bombay Super Hybrid Seeds Ltd stock price is INR ₹84.0. On the other hand, GKB Ophthalmics Ltd stock price is INR ₹60.84.

How do dividend payouts of Bombay Super Hybrid Seeds Ltd and GKB Ophthalmics Ltd compare?

To compare the dividend payouts of Bombay Super Hybrid Seeds Ltd and GKB Ophthalmics Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.